Timothy J. Whelan

Timothy J. Whelan

Auto-generated profile, based on publicly available information

Timothy J. Whelan

McMaster University, Hamilton, ON, Canada

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
TWTimothy J. Whelan
Timothy J. Whelan
IOIvo A. Olivotto
Ivo A. Olivotto
WPWendy R. Parulekar
Wendy R. Parulekar
IAIda Ackerman
Ida Ackerman
BCBoon H. Chua
Boon H. Chua
MLMark N. Levine
Mark N. Levine
Most women with breast cancer who undergo breast-conserving surgery receive whole-breast irradiation. We examined whether the addition of regional nodal irradiation to whole-breast irradiation improved outcomes. We randomly assigned women with node-positive or high-risk node-negative breast cancer who were treated with breast-conserving surgery and adjuvant systemic therapy to undergo either whole-breast irradiation plus regional nodal irradiation (including internal mammary, supraclavicular, and axillary lymph nodes) (nodal-irradiation group) or whole-breast irradiation alone (control group). The primary outcome was overall survival. Secondary outcomes were disease-free survival, isolated locoregional disease-free survival, and distant disease-free survival. Between March 2000 and February 2007, a total of 1832 women were assigned to the nodal-irradiation group or the control group (916 women in each group). The median follow-up was 9.5 years. At the 10-year follow-up, there was no significant between-group difference in survival, with a rate of 82.8% in the nodal-irradiation group and 81.8% in the control group (hazard ratio, 0.91; 95% confidence interval [CI], 0.72 to 1.13; P=0.38). The rates of disease-free survival were 82.0% in the nodal-irradiation group and 77.0% in the control group (hazard ratio, 0.76; 95% CI, 0.61 to 0.94; P=0.01). Patients in the nodal-irradiation group had higher rates of grade 2 or greater acute pneumonitis (1.2% vs. 0.2%, P=0.01) and lymphedema (8.4% vs. 4.5%, P=0.001). Among women with node-positive or high-risk node-negative breast cancer, the addition of regional nodal irradiation to whole-breast irradiation did not improve overall survival but reduced the rate of breast-cancer recurrence. (Funded by the Canadian Cancer Society Research Institute and others; MA.20 ClinicalTrials.gov number, NCT00005957.)

1 December 2019 in The Lancet
Verified
Journal Article
Closed access
TWTimothy J Whelan
Timothy J Whelan
JJJim A Julian
Jim A Julian
TBTanya S Berrang
Tanya S Berrang
DKDo-Hoon Kim
Do-Hoon Kim
IGIsabelle Germain
Isabelle Germain
CFChristopher Ford
Christopher Ford

1 April 2015 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
DPDavid Peterson
David Peterson
PTPauline T Truong
Pauline T Truong
SPSameer Parpia
Sameer Parpia
IOIvo A Olivotto
Ivo A Olivotto
TBTanya Berrang
Tanya Berrang
RIRAPID trial investigators
RAPID trial investigators

1 August 2020 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
JAJulie Arsenault
Julie Arsenault
SPSameer Parpia
Sameer Parpia
MGMira Goldberg
Mira Goldberg
EREileen Rakovitch
Eileen Rakovitch
HRHarold Reiter
Harold Reiter
TWTimothy Whelan
Timothy Whelan

1 July 2003 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
EWEric P. Winer
Eric P. Winer
CHClifford Hudis
Clifford Hudis
HBHarold J. Burstein
Harold J. Burstein
JBJohn Bryant
John Bryant
RCRowan T. Chlebowski
Rowan T. Chlebowski
GBGeorge P. Browman
George P. Browman

22 September 2022 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
MGMira Goldberg
Mira Goldberg
JBJidapa Bridhikitti
Jidapa Bridhikitti
AKAtif J. Khan
Atif J. Khan
PMPaul McGale
Paul McGale
TWTimothy J. Whelan
Timothy J. Whelan